Horizon Discovery Group has appointed Terry Pizzie as CEO and board member, effective immediately. Pizzie joined Horizon in 2017 as head of commercial operations and has nearly 30 years of experience in the biotechnology tools sector. Prior to joining Horizon, Pizzie worked for Pacific Biosciences, first as a VP in Europe, and later as head of global sales. His previous leadership roles include director of global commercial operations at Genetix prior to its acquisition by Danaher, and senior vice president of global commercial operations at Swedish biotech firm Biacore. He started his career at Applied Biosystems in 1988.
Stephanie Bywater has been appointed chief compliance officer at NeoGenomics, effective May 1. She replaces Steven Jones, who will remain an executive VP and board member at the company. Bywater has been a compliance officer at NeoGenomics since she joined the firm in May 2017. She previously served as global compliance operations and Americas compliance officer at Varian Medical Systems, and as compliance and privacy officer for Myriad Genetics.
Michael Stocum has stepped down as CEO of Inivata "to pursue other interests," according to the company. Inivata said it has initiated a search for a new CEO.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.